Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.

Por Ray, R, Meyer, K, Newman, F K, Belshe, R B
Publicado em 1995

Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytom...

Por Gorse, G J, Frey, S E, Newman, F K, Belshe, R B
Publicado em 1992

Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children.

Por Anderson, E L, Newman, F K, Maassab, H F, Belshe, R B
Publicado em 1992

Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene.

Por Ray, R, Galinski, M S, Heminway, B R, Meyer, K, Newman, F K, Belshe, R B
Publicado em 1996

Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.

Por Gorse, G J, Patel, G B, Newman, F K, Belshe, R B, Berman, P W, Gregory, T J, Matthews, T J
Publicado em 1996

Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children.

Por Belshe, R B, Karron, R A, Newman, F K, Anderson, E L, Nugent, S L, Steinhoff, M, Clements, M L, Wilson, M H, Hall, S L, Tierney, E L
Publicado em 1992